Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:42:47 EDT Wed 08 May 2024
Enter Symbol
or Name
USA
CA



Q:INO - INOVIO PHARMACEUTICALS INC - http://www.inovio.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
INO - Q0.211.02·11.070.111.07-0.08-0.724.125326311.00  11.2952  10.9014.748  3.88810:22:27May 0115 min RT 2¢

Recent Trades - Last 10 of 263
Time ETExPriceChangeVolume
10:22:27Q11.11-0.04100
10:22:27Q11.11-0.04100
10:22:27Q11.11-0.043
10:22:27Q11.11-0.04100
10:22:27Q11.11-0.04100
10:22:27Q11.11-0.042
10:22:27Q11.09-0.061
10:22:27Q11.09-0.061
10:22:27Q11.07-0.08100
10:22:26Q11.13-0.02100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-05-01 08:00U:INONews ReleaseINOVIO Reports Inducement Grants Under Inducement Plan
2024-04-29 08:00U:INONews ReleaseINOVIO to Participate in Upcoming Investor Conferences in May
2024-04-29 08:00U:INONews ReleaseINOVIO to Report First Quarter 2024 Financial Results on May 13, 2024
2024-04-15 18:39U:INONews ReleaseINOVIO Announces Pricing of Approximately $36 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
2024-03-26 18:28U:INONews ReleaseINOVIO to Participate in The Citizens JMP Novel Therapeutics Forum at Penn Medicine
2024-03-06 16:05U:INONews ReleaseINOVIO Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
2024-03-06 07:00U:INONews ReleaseGeneos Therapeutics to Present New Clinical Data on GNOS-PV02 at the 2024 American Association for Cancer Research (AACR) Annual Meeting
2024-02-21 08:00U:INONews ReleaseINOVIO to Report Fourth Quarter and Year-End 2023 Financial Results on March 6, 2024
2024-02-07 11:46U:INONews ReleaseINOVIO to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
2024-02-02 08:00U:INONews ReleaseINOVIO Reports Inducement Grant Under Inducement Plan
2024-01-23 08:00U:INONews ReleaseINOVIO Announces Effective Date of 1-for-12 Reverse Stock Split
2024-01-22 08:00U:INONews ReleaseINOVIO to Participate in Virtual Fireside Chat on the Potential Treatment of Recurrent Respiratory Papillomatosis with Key Opinion Leader
2024-01-04 08:00U:INONews ReleaseINOVIO and Coherus Announce Clinical Collaboration to Advance Development of INO-3112 in Combination with LOQTORZI ¢ „ ¢ (toripalimab-tpzi)
2024-01-03 08:00U:INONews ReleaseINOVIO Plans to Submit a BLA for INO-3107 as a Potential Treatment for RRP in Second Half of 2024 Under Accelerated Approval Program
2023-11-09 16:05U:INONews ReleaseINOVIO Reports Third Quarter 2023 Financial Results and Operational Highlights
2023-11-01 08:00U:INONews ReleaseINOVIO Reports Inducement Grants Under Inducement Plan
2023-10-26 08:00U:INONews ReleaseINOVIO to Report Third Quarter 2023 Financial Results on November 9, 2023
2023-10-10 08:00U:INONews ReleaseINOVIO Receives FDA Feedback that Data from Completed Phase 1/2 Trial of INO-3107 Can Be Used to Submit a BLA Under Accelerated Approval Program
2023-09-27 19:39U:INONews ReleaseGeneos Therapeutics Closes its Series A3 Financing With Investment of $5 Million
2023-09-07 08:00U:INONews ReleaseINOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis